Strategies of lymphocyte activation for the adoptive immunotherapy of metastatic cancer: a review

J Hematother. Spring 1993;2(1):63-73. doi: 10.1089/scd.1.1993.2.63.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Forecasting
  • Humans
  • Immunotherapy, Adoptive / methods*
  • Interleukin-2 / pharmacology
  • Killer Cells, Lymphokine-Activated / immunology
  • Killer Cells, Lymphokine-Activated / transplantation
  • Lymph Nodes / pathology
  • Lymphocyte Activation*
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Lymphocytes, Tumor-Infiltrating / transplantation
  • Melanoma, Experimental / therapy
  • Mice
  • Mice, Inbred C57BL
  • Muromonab-CD3 / pharmacology
  • Neoplasm Metastasis
  • Neoplasms / therapy*
  • Sarcoma, Experimental / therapy
  • T-Lymphocyte Subsets / drug effects
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / transplantation*

Substances

  • Interleukin-2
  • Muromonab-CD3